BR112012008310A2 - métodos para tratamento de tumores cerebrais - Google Patents

métodos para tratamento de tumores cerebrais

Info

Publication number
BR112012008310A2
BR112012008310A2 BR112012008310A BR112012008310A BR112012008310A2 BR 112012008310 A2 BR112012008310 A2 BR 112012008310A2 BR 112012008310 A BR112012008310 A BR 112012008310A BR 112012008310 A BR112012008310 A BR 112012008310A BR 112012008310 A2 BR112012008310 A2 BR 112012008310A2
Authority
BR
Brazil
Prior art keywords
brain tumors
methods
treating brain
treating
tumors
Prior art date
Application number
BR112012008310A
Other languages
English (en)
Inventor
Jin Yang Yong
Joon Jo Yong
Original Assignee
Kominox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kominox Inc filed Critical Kominox Inc
Publication of BR112012008310A2 publication Critical patent/BR112012008310A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

método para tratamento de tumores cerebrais. a presente invenção refere-se a métodos de tratamento de tumores cerebrais compreendendo a administração de um indivíduo com essa necessidade de uma quantidade terapeuticamente eficaz de sódio meta arsenito, sozinho ou em combinação com o outro medicamento antitumor do cérebro.
BR112012008310A 2009-09-18 2010-09-09 métodos para tratamento de tumores cerebrais BR112012008310A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24364809P 2009-09-18 2009-09-18
PCT/US2010/048314 WO2011034775A2 (en) 2009-09-18 2010-09-09 Methods for treating brain tumors

Publications (1)

Publication Number Publication Date
BR112012008310A2 true BR112012008310A2 (pt) 2017-06-06

Family

ID=43756836

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012008310A BR112012008310A2 (pt) 2009-09-18 2010-09-09 métodos para tratamento de tumores cerebrais

Country Status (15)

Country Link
US (1) US20110070314A1 (pt)
EP (1) EP2477635A4 (pt)
JP (1) JP2013505242A (pt)
KR (1) KR20120048706A (pt)
CN (1) CN102753188A (pt)
AR (1) AR078170A1 (pt)
AU (1) AU2010295841A1 (pt)
BR (1) BR112012008310A2 (pt)
CA (1) CA2772777A1 (pt)
IN (1) IN2012DN02195A (pt)
MX (1) MX2012002922A (pt)
RU (1) RU2012108439A (pt)
SG (1) SG179192A1 (pt)
TW (1) TW201114431A (pt)
WO (1) WO2011034775A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2475362T (lt) * 2009-09-10 2019-06-10 Kominox, Inc. Tikslinė vėžinių kamieninių ląstelių ir atsparaus vaistams vėžio terapija
KR101309036B1 (ko) * 2011-05-30 2013-09-16 주식회사 코미팜 방사선 민감도 증진용 약학 조성물
US8781202B2 (en) * 2012-07-26 2014-07-15 International Business Machines Corporation Tumor classification based on an analysis of a related ultrasonic attenuation map
US10076652B2 (en) * 2015-08-10 2018-09-18 Chang Gung University Method for ultrasound-mediated delivery system to monitor molecular penetration
MA52088A (fr) * 2018-03-22 2021-01-27 Komipharm Int Australia Pty Ltd Composition pharmaceutique comprenant du méta-arsénite et procédé de fabrication
KR20220020637A (ko) * 2020-08-12 2022-02-21 이상봉 항암화학요법이나 방사선요법으로 인한 암 환자의 탈모증을 포함한 탈모증 환자에 대하여 탈모를 방지하고 발모를 촉진하는 메타아르세나이트의 염을 함유하는 경구 투여용 약학적 조성물
KR20220020633A (ko) * 2020-08-12 2022-02-21 이상봉 탈모방지 또는 발모촉진용 주사제 조성물
KR20220020635A (ko) * 2020-08-12 2022-02-21 이상봉 탈모방지 또는 발모촉진용 외용제 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU751932B2 (en) * 1997-10-15 2002-08-29 Polarx Biopharmaceuticals, Inc. Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
KR20020083678A (ko) * 2001-04-28 2002-11-04 주식회사 한국미생물연구소 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물
CN1298332C (zh) * 2002-04-10 2007-02-07 韩国微生物实验室有限公司 用于治疗恶性肿瘤的包含亚砷酸盐的药物组合物
WO2006104292A1 (en) * 2005-03-31 2006-10-05 Komipharm International Co., Ltd. Pharmaceutical composition comprising arsenic acid, meta-arsenite, and pharmaceutically acceptable salts
EP1721615A1 (en) * 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis

Also Published As

Publication number Publication date
CN102753188A (zh) 2012-10-24
AU2010295841A1 (en) 2012-03-29
WO2011034775A2 (en) 2011-03-24
US20110070314A1 (en) 2011-03-24
SG179192A1 (en) 2012-05-30
RU2012108439A (ru) 2013-10-27
AR078170A1 (es) 2011-10-19
MX2012002922A (es) 2012-09-07
KR20120048706A (ko) 2012-05-15
JP2013505242A (ja) 2013-02-14
EP2477635A4 (en) 2013-03-27
EP2477635A2 (en) 2012-07-25
WO2011034775A3 (en) 2011-10-06
IN2012DN02195A (pt) 2015-08-21
TW201114431A (en) 2011-05-01
CA2772777A1 (en) 2011-03-24

Similar Documents

Publication Publication Date Title
BR112012008310A2 (pt) métodos para tratamento de tumores cerebrais
CY1124307T1 (el) Φαρμακευτικη συνθεση, μεθοδοι θεραπειας και χρησεις αυτων
PH12018502234B1 (en) Treatment of cancer with tor kinase inhibitors
BR112015022197A2 (pt) tratamento de cataplexia
BR112013031032A2 (pt) inibidores de sglt-2 para o tratamento de distúrbios metabólicos em pacientes tratados com agentes neurolépticos
GT201400191A (es) Esketamina para el tratamiento de la depresión refractaria al tratamiento o resistente al tratamiento
BR112013002012A2 (pt) métodos e composições para terapia de câncer de fígado
BR112012030699A2 (pt) métodos para tratar câncer de bexiga
BR112013023803A2 (pt) dispositivo para inervação magnética extracorpórea
UA115231C2 (uk) Сполуки імідазопіролідинонів
CR20120202A (es) Métodos y composiciones para tratar cáncer
BR112014008294A2 (pt) anticorpo anti c-met e usos do mesmo
BR112013006673A2 (pt) produtos terapêuticos para câncer de mama
EA201690728A1 (ru) Применение молекул, связывающих семафорин-4d, для лечения атеросклероза
MX2020010004A (es) Composicion farmaceutica que comprende empagliflozina, metodos para tratamiento y sus usos.
EA201492067A1 (ru) Применение связывающих семафорин-4d молекул для промотирования нейрогенеза после инсульта
BR112012033738A2 (pt) método para o tratamento de transtorno bipolar
BR112015003729A2 (pt) composto de fórmula estrutural i; composição farmacêutica; método de tratamento de uma doença mediada por caminho do hif; método de tratamento de uma doença causada por proliferação anormal de células; e método para alcançar um efeito em um paciente
MX2015014599A (es) Terapia de combinacion que comprende un inhibidor de tor cinasa y un analogo de citidina para tracar cancer.
BR112015033069A2 (pt) moduladores de receptor do hormônio de crescimento
BR112014019399A2 (pt) métodos de tratamento da fibrose
SG10201810575WA (en) Treatment of prostate cancer with tor kinase inhibitors
BR112014011223A8 (pt) Método de tratar uma doença proliferativa
BR112014006473A2 (pt) composição e método para tratamento de uma doença autoimune
BR112012019920A2 (pt) derivados de piridazina úteis como agonístas de canabinoide-2.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]